2[3]Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J cardiol, 1998,61: 83 被引量:1
3Shawn AG, Jacob BW, Gregory DC. Acute hepatitis induced by parenteral amiodarone. Am J Med, 2002, 113:254-255. 被引量:1
4Tisdale JE,Follin SL,0rdelova A,et al. Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone.J Clin Pharmacol,1995,35:351-356. 被引量:1
5Morganroth J. Risk factors for the development of proarrythmic events[J]. Am J Cardiol, 1987, 59:32-37. 被引量:1